| Previous Close | 64.53 |
| Open | 64.56 |
| Bid | 65.04 x 100 |
| Ask | 65.64 x 400 |
| Day's Range | 64.56 - 65.60 |
| 52 Week Range | 55.10 - 66.80 |
| Volume | 6 |
| Avg. Volume | 8,881,409 |
| Market Cap | 179.04B |
| Beta | 0.97 |
| PE Ratio (TTM) | 41.72 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.88 (2.91%) |
| Ex-Dividend Date | 2017-06-13 |
| 1y Target Est | N/A |
- CNBC•16 hours ago
S&P closes lower after oil drops more than 2% again
U.S. stocks traded mostly lower on Wednesday as oil prices failed to rebound from a sharp fall during the previous session.
- Forbes•18 hours ago
Amgen An Undervalued Industry Leader
Given the company’s industry leading position, solid fundamentals and attractive stock valuation, we view it as a preferable alternative to traditional competitors in its industry.
- TheStreet.com•19 hours ago
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.
